Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)

Verywell Mind

Using Wellbutrin for ADHD

Family Medicine/General Practice June 17th 2025

MedCentral

Nearly 1.5 Million Bottles of Glenmark’s ADHD Drug Atomoxetine Recalled

Clinical Pharmacology April 1st 2025

Psych Congress Network

Methylphenidate Improved Driving Performance in Adults

Clinical Pharmacology February 21st 2025

Medical News Today (MNT)

ADHD Linked to ‘Astonishing’ Reduction in Life Expectancy

Pediatrics February 12th 2025

Psych Congress Network

Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy

Neurology January 22nd 2025

GoodRx for Healthcare Professionals

Adderall Shortage and New Generics Lead to Changes in Types of ADHD Medications Used

Family Medicine/General Practice September 3rd 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form